Istaroxime significantly improved the systolic blood pressure profile WARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced positive primary results with istaroxime in rapidly raising systolic blood pressure, the […]
Coronary/Structural Heart
Translumina launches VIVO ISAR, its Dual-Drug Polymer-free Coated Stent (DDCS) in International markets
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company’s global growth journey NEW DELHI and HECHINGEN, Germany, April 19, 2022 /PRNewswire/ — Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology, announces the launch of VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in […]
ASPC Announces Official Program Covering the ABCs of Preventive Cardiology at Premier Annual Congress on CVD Prevention
JACKSONVILLE, Fla., April 18, 2022 /PRNewswire/ — The American Society for Preventive Cardiology (ASPC) announces the official program for the ASPC 2022 Congress on CVD Prevention, scheduled July 29-31, 2022 in Louisville, KY. The program covers the “ABCs of Preventive Cardiology” over the 2.5 day live, in-person program, and can be found on aspconline.org/2022congress. Included in the […]
Baxter Highlights New Data at SCCM Critical Care Congress Showing Hemodynamic Monitoring May Help Predict Patient Outcomes
Findings suggest that monitoring changes in stroke volume and cardiac output could help predict mortality in critically ill patients Baxter-sponsored symposium advances expert dialogue on fluid management DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the findings of an observational […]
Children’s Hospital of Philadelphia Launches Research Institute Dedicated to Advancing the Care of Pediatric Cardiovascular Diseases
— Led by director of Penn Cardiovascular Institute (Penn CVI), CHOP CVI combines the best of CHOP and Penn Medicine to drive scientific discovery– PHILADELPHIA, April 18, 2022 /PRNewswire/ — Deepening its commitment to pediatric cardiovascular research, the Children’s Hospital of Philadelphia (CHOP) Research Institute has launched the CHOP Cardiovascular Institute (CHOP CVI). Led by Daniel […]
CareDx Reports Over 200,000 Heart Transplant Patient Results Served
CareDx Testing Services Have Been Used in Over 30,000 Heart Transplant Patients and Over 90 Percent of Centers in the United States SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, […]
Multi-Site Clinical Validation of Prospera Heart Test Demonstrates Outstanding Performance in Assessing Heart Transplant Rejection
DEDUCE study demonstrates AUC of 0.86 in overall cohort, including more than 700 prospective samples AUSTIN, Texas, April 13, 2022 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that its clinical validation study1 on its donor-derived cell-free DNA (dd-cfDNA) test for the assessment of acute rejection in heart transplant patients, […]
Esperion Announces Publication of Phase 3 Data for Bempedoic Acid in the Journal of Clinical Lipidology
Analysis of pooled Phase 3 data demonstrated 26.5% reduction vs. placebo in LDL-C from bempedoic acid monotherapy and 39.2% reduction vs. placebo in LDL-C from bempedoic acid and ezetimibe fixed-dose combination in patients not taking statins ANN ARBOR, Mich., April 13, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced […]
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures
Intuitive monitor featuring patient-tailored approach is now in clinical use in select centers in U.S. and Europe LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced receipt of regulatory approvals and the start of a targeted commercial launch for the Essenz™ Patient Monitor. The transformative monitoring […]
Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-driven HART CVE Blood Test Highly Accurate in Patients with Diabetes for Predicting Heart Attack, Stroke, and Cardiac Death Risk
Novel multi-protein blood test data on 450 patients presented at 2022 American College of Cardiology Scientific Sessions KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces the presentation of patient data demonstrating its Artificial Intelligence (AI)-driven HART CVE blood test is highly accurate in determining whether a person with diabetes will have a heart attack […]
Recent
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency
Popular
- No commented posts yet